US6323307B1
(en)
|
1988-08-08 |
2001-11-27 |
Cargill Dow Polymers, Llc |
Degradation control of environmentally degradable disposable materials
|
US5247058A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5258488A
(en)
*
|
1992-01-24 |
1993-11-02 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US6326458B1
(en)
|
1992-01-24 |
2001-12-04 |
Cargill, Inc. |
Continuous process for the manufacture of lactide and lactide polymers
|
US6005067A
(en)
|
1992-01-24 |
1999-12-21 |
Cargill Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5247059A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for the manufacture of a purified lactide from esters of lactic acid
|
US5142023A
(en)
*
|
1992-01-24 |
1992-08-25 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US6005068A
(en)
*
|
1992-10-02 |
1999-12-21 |
Cargill Incorporated |
Melt-stable amorphous lactide polymer film and process for manufacture thereof
|
DE69322155T2
(de)
*
|
1992-10-02 |
1999-08-19 |
Cargill Inc |
Papier mit einer beschichtung aus schmelzstabilem polymer und dessen verfahren zur herstellung
|
DK0615555T3
(da)
*
|
1992-10-02 |
2001-07-09 |
Cargill Inc |
Tekstilmateriale af smeltestabil lactidpolymer og fremgangsmåde til fremstilling deraf
|
US5338822A
(en)
*
|
1992-10-02 |
1994-08-16 |
Cargill, Incorporated |
Melt-stable lactide polymer composition and process for manufacture thereof
|
TW333456B
(en)
*
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
UA61046C2
(en)
*
|
1992-12-07 |
2003-11-17 |
Takeda Chemical Industries Ltd |
Sustained-release preparation and method for its manufacture
|
ES2290074T3
(es)
|
1993-07-19 |
2008-02-16 |
Angiotech Pharmaceuticals, Inc. |
Composiciones anti-angiogenicas que contienen taxol y un vehiculo no biodegradable y su uso.
|
US5716981A
(en)
*
|
1993-07-19 |
1998-02-10 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic compositions and methods of use
|
US5424289A
(en)
*
|
1993-07-30 |
1995-06-13 |
Alza Corporation |
Solid formulations of therapeutic proteins for gastrointestinal delivery
|
US5594091A
(en)
*
|
1994-02-21 |
1997-01-14 |
Takeda Chemical Industries, Ltd. |
Matrix for sustained-release preparation
|
FR2718642B1
(fr)
*
|
1994-04-15 |
1996-07-12 |
Pf Medicament |
Microsphères biodégradables à libération contrôlée et leur procédé de préparation.
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
JP2987064B2
(ja)
*
|
1994-09-12 |
1999-12-06 |
グンゼ株式会社 |
人工硬膜
|
US6117455A
(en)
*
|
1994-09-30 |
2000-09-12 |
Takeda Chemical Industries, Ltd. |
Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
|
EP0753539B1
(en)
*
|
1995-07-13 |
2001-10-10 |
Mitsubishi Gas Chemical Company, Inc. |
Aliphatic polyester polymer blends based on poly(lactic acid), methods for manufacturing the same, and methods for molding the same
|
EP0765660A3
(en)
*
|
1995-09-28 |
1998-09-23 |
Takeda Chemical Industries, Ltd. |
Microcapsules comprising 2-piperazinone-1-acetic acid compounds
|
US5637085A
(en)
*
|
1995-11-20 |
1997-06-10 |
Cardinale; Robert M. |
Method of cancer tumor treatment by slow release delivery of 1,2,4-benzotriazine oxides to tumor site
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
CA2192782C
(en)
|
1995-12-15 |
2008-10-14 |
Nobuyuki Takechi |
Production of microspheres
|
FR2744367B1
(fr)
*
|
1996-02-02 |
1999-07-09 |
Emperaire Jean Claude |
Medicaments pour le declenchement de l'ovulation
|
CA2241322C
(en)
*
|
1996-03-28 |
2009-01-13 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation and its production
|
ATE302599T1
(de)
|
1996-05-24 |
2005-09-15 |
Angiotech Pharm Inc |
Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
|
JP4317599B2
(ja)
*
|
1996-06-26 |
2009-08-19 |
武田薬品工業株式会社 |
徐放性製剤
|
US7435425B2
(en)
*
|
2001-07-17 |
2008-10-14 |
Baxter International, Inc. |
Dry hemostatic compositions and methods for their preparation
|
US6066325A
(en)
*
|
1996-08-27 |
2000-05-23 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
US8303981B2
(en)
|
1996-08-27 |
2012-11-06 |
Baxter International Inc. |
Fragmented polymeric compositions and methods for their use
|
US8603511B2
(en)
|
1996-08-27 |
2013-12-10 |
Baxter International, Inc. |
Fragmented polymeric compositions and methods for their use
|
US7871637B2
(en)
|
1996-08-27 |
2011-01-18 |
Baxter International Inc. |
Dry hemostatic compositions and methods for their preparation
|
US7235524B2
(en)
*
|
1997-01-31 |
2007-06-26 |
Applied Research System Ars Holding N.V. |
Medicaments for initiating ovulation
|
US5945126A
(en)
*
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
WO1998044021A1
(en)
|
1997-04-03 |
1998-10-08 |
Guilford Pharmaceuticals Inc. |
Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same
|
US6051558A
(en)
*
|
1997-05-28 |
2000-04-18 |
Southern Biosystems, Inc. |
Compositions suitable for controlled release of the hormone GnRH and its analogs
|
ZA987019B
(en)
*
|
1997-08-06 |
1999-06-04 |
Focal Inc |
Hemostatic tissue sealants
|
KR19990065921A
(ko)
*
|
1998-01-19 |
1999-08-16 |
김충섭 |
항생제의서방성제제
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US6419709B1
(en)
|
1998-10-02 |
2002-07-16 |
Guilford Pharmaceuticals, Inc. |
Biodegradable terephthalate polyester-poly(Phosphite) compositions, articles, and methods of using the same
|
US6153212A
(en)
*
|
1998-10-02 |
2000-11-28 |
Guilford Pharmaceuticals Inc. |
Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same
|
US6270802B1
(en)
|
1998-10-28 |
2001-08-07 |
Oakwood Laboratories L.L.C. |
Method and apparatus for formulating microspheres and microcapsules
|
GB2344287A
(en)
*
|
1998-12-03 |
2000-06-07 |
Ferring Bv |
Controlled release pharmaceutical formulation
|
BR9916117A
(pt)
*
|
1998-12-15 |
2001-09-04 |
Wolff Walsrode Ag |
Corpos moldados termoplásticos, biodegradáveis, exibindo uma estabilidade melhorada com respeito à hidrólise e uma resistência melhorada à rachadura por tensão
|
US6350464B1
(en)
|
1999-01-11 |
2002-02-26 |
Guilford Pharmaceuticals, Inc. |
Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
|
US6537585B1
(en)
|
1999-03-26 |
2003-03-25 |
Guilford Pharmaceuticals, Inc. |
Methods and compositions for treating solid tumors
|
CA2432904C
(en)
|
2000-12-21 |
2007-09-11 |
Nektar Therapeutics |
Induced phase transition method for the production of microparticles containing hydrophobic active agents
|
CN1098883C
(zh)
*
|
2000-12-28 |
2003-01-15 |
武汉大学 |
分散度均匀的聚乳酸微球制备新方法
|
WO2003000156A1
(en)
|
2001-06-22 |
2003-01-03 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
CA2452412C
(en)
|
2001-06-29 |
2011-05-24 |
Medgraft Microtech, Inc. |
Biodegradable injectable implants and related methods of manufacture and use
|
CN101444476B
(zh)
*
|
2001-12-26 |
2011-11-30 |
武田药品工业株式会社 |
新微球和其生产方法
|
JP2003192773A
(ja)
*
|
2001-12-26 |
2003-07-09 |
Mitsui Chemicals Inc |
生体吸収性ポリヒドロキシカルボン酸及びその製造法
|
US20040197301A1
(en)
*
|
2003-02-18 |
2004-10-07 |
Zhong Zhao |
Hybrid polymers and methods of making the same
|
US8834864B2
(en)
*
|
2003-06-05 |
2014-09-16 |
Baxter International Inc. |
Methods for repairing and regenerating human dura mater
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
US20080287400A1
(en)
*
|
2004-05-24 |
2008-11-20 |
Richard John Dansereau |
Low Dosage Forms Of Risedronate Or Its Salts
|
US7645459B2
(en)
*
|
2004-05-24 |
2010-01-12 |
The Procter & Gamble Company |
Dosage forms of bisphosphonates
|
US20080286359A1
(en)
*
|
2004-05-24 |
2008-11-20 |
Richard John Dansereau |
Low Dosage Forms Of Risedronate Or Its Salts
|
US7645460B2
(en)
*
|
2004-05-24 |
2010-01-12 |
The Procter & Gamble Company |
Dosage forms of risedronate
|
JP4599567B2
(ja)
*
|
2004-10-20 |
2010-12-15 |
国立大学法人群馬大学 |
温度応答性デプシペプチドポリマー
|
CN1923281B
(zh)
*
|
2005-08-30 |
2010-05-05 |
孔庆忠 |
一种含植物生物碱的抗癌缓释注射剂
|
CA2636716C
(en)
*
|
2006-01-13 |
2014-12-23 |
Surmodics, Inc. |
Microparticle containing matrices for drug delivery
|
US8703122B2
(en)
*
|
2006-05-31 |
2014-04-22 |
Baxter International Inc. |
Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
|
TWI436793B
(zh)
|
2006-08-02 |
2014-05-11 |
Baxter Int |
快速作用之乾密封膠及其使用和製造方法
|
KR100845009B1
(ko)
*
|
2007-08-07 |
2008-07-08 |
한국생명공학연구원 |
전하를 띠는 물질이 고착된 다공성 고분자 입자 및 그제조방법
|
AR069109A1
(es)
|
2007-10-30 |
2009-12-30 |
Baxter Int |
Uso de una biomatriz de colageno biofuncional regenerativa para tratar defectos viscerales o parietales
|
CN102014973A
(zh)
|
2008-02-29 |
2011-04-13 |
弗罗桑医疗设备公司 |
用于促进止血和/或伤口愈合的装置
|
US9039783B2
(en)
|
2009-05-18 |
2015-05-26 |
Baxter International, Inc. |
Method for the improvement of mesh implant biocompatibility
|
CN102802683B
(zh)
*
|
2009-06-16 |
2015-11-25 |
巴克斯特国际公司 |
止血海绵
|
JPWO2011024944A1
(ja)
*
|
2009-08-31 |
2013-01-31 |
国立大学法人豊橋技術科学大学 |
ステレオコンプレックスポリエステル及びその製造方法
|
KR101811070B1
(ko)
*
|
2009-12-16 |
2017-12-20 |
백스터 인터내셔널 인코포레이티드 |
지혈 스폰지
|
SA111320355B1
(ar)
|
2010-04-07 |
2015-01-08 |
Baxter Heathcare S A |
إسفنجة لايقاف النزف
|
CN103037845B
(zh)
|
2010-06-01 |
2015-11-25 |
巴克斯特国际公司 |
用于制备干燥、稳定的止血组合物的方法
|
JP5973997B2
(ja)
|
2010-06-01 |
2016-08-23 |
バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated |
乾燥した安定な止血用組成物を作製するためのプロセス
|
WO2011151400A1
(en)
|
2010-06-01 |
2011-12-08 |
Baxter International Inc. |
Process for making dry and stable hemostatic compositions
|
JP6147664B2
(ja)
*
|
2010-07-26 |
2017-06-14 |
ユニベルシテ ドゥ ジュネーブ |
2−ヒドロキシアルキル酸から調製されたポリマーを含む組成物
|
MX356185B
(es)
|
2011-10-11 |
2018-05-17 |
Baxter Int |
Composiciones hemostaticas.
|
US20130090291A1
(en)
|
2011-10-11 |
2013-04-11 |
Baxter Healthcare S.A. |
Hemostatic compositions
|
SG11201401878SA
(en)
|
2011-10-27 |
2014-09-26 |
Baxter Int |
Hemostatic compositions
|
EP2822474B1
(en)
|
2012-03-06 |
2018-05-02 |
Ferrosan Medical Devices A/S |
Pressurized container containing haemostatic paste
|
BR112014030962A2
(pt)
|
2012-06-12 |
2017-06-27 |
Ferrosan Medical Devices As |
métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
|
US9724078B2
(en)
|
2013-06-21 |
2017-08-08 |
Ferrosan Medical Devices A/S |
Vacuum expanded dry composition and syringe for retaining same
|
EP3470094B1
(en)
|
2013-12-11 |
2020-07-22 |
Ferrosan Medical Devices A/S |
Dry composition comprising an extrusion enhancer
|
WO2016058612A1
(en)
|
2014-10-13 |
2016-04-21 |
Ferrosan Medical Devices A/S |
Dry composition for use in haemostasis and wound healing
|
WO2016102446A1
(en)
|
2014-12-24 |
2016-06-30 |
Ferrosan Medical Devices A/S |
Syringe for retaining and mixing first and second substances
|
WO2017005590A1
(en)
|
2015-07-03 |
2017-01-12 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
JP6148701B2
(ja)
*
|
2015-07-31 |
2017-06-14 |
ユニベルシテ ドゥ ジュネーブ |
2−ヒドロキシアルキル酸から調製されたポリマーを含む組成物
|
CN105111417A
(zh)
*
|
2015-08-25 |
2015-12-02 |
杭州铭众生物科技有限公司 |
一种羟基乙酸-羟基丙酸无规共聚物的制备方法
|
EP4321182A2
(en)
|
2018-05-09 |
2024-02-14 |
Ferrosan Medical Devices A/S |
Method for preparing a haemostatic composition
|